Search details
1.
Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.
Br J Clin Pharmacol
; 90(4): 976-986, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38072829
2.
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.
Br J Clin Pharmacol
; 90(5): 1312-1321, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38373846
3.
Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer.
Cell Mol Life Sci
; 79(6): 284, 2022 May 08.
Article
in English
| MEDLINE | ID: mdl-35526196
4.
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model.
Br J Clin Pharmacol
; 88(7): 3500-3505, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35043423
5.
Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study.
Br J Clin Pharmacol
; 87(5): 2236-2246, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33118186
6.
Association of IgG1 Antibody Clearance with FcγRIIA Polymorphism and Platelet Count in Infliximab-Treated Patients.
Int J Mol Sci
; 22(11)2021 Jun 03.
Article
in English
| MEDLINE | ID: mdl-34205175
7.
Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
J Pediatr
; 204: 225-233.e8, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30314658
8.
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report.
Blood
; 129(19): 2616-2623, 2017 05 11.
Article
in English
| MEDLINE | ID: mdl-28251914
9.
CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis.
Br J Clin Pharmacol
; 85(12): 2747-2758, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31454097
10.
Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot study.
Br J Clin Pharmacol
; 85(9): 2002-2010, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31112622
11.
New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases.
Br J Clin Pharmacol
; 85(4): 722-728, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30575085
12.
IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding.
J Immunol
; 196(2): 607-13, 2016 Jan 15.
Article
in English
| MEDLINE | ID: mdl-26685205
13.
A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.
BMC Cancer
; 17(1): 220, 2017 03 27.
Article
in English
| MEDLINE | ID: mdl-28347290
14.
Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.
Br J Clin Pharmacol
; 83(8): 1773-1781, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28230269
15.
Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis.
Ther Drug Monit
; 39(4): 364-369, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28700520
16.
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases.
Ther Drug Monit
; 39(4): 339-343, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28486309
17.
Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling.
Ther Drug Monit
; 39(4): 322-326, 2017 08.
Article
in English
| MEDLINE | ID: mdl-28703717
18.
Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publications.
Br J Clin Pharmacol
; 87(3): 1594-1595, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33269471
19.
Intravenous and subcutaneous administration of trastuzumab in a patient on peritoneal dialysis.
Br J Clin Pharmacol
; 87(8): 3372-3374, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33464605
20.
Influence of tumour burden on trastuzumab pharmacokinetics in HER2 positive non-metastatic breast cancer.
Br J Clin Pharmacol
; 81(5): 941-8, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26714164